Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Athira Pharma Q2 EPS $(0.65) Down From $(0.38) YoY

Athira Pharma Q2 EPS $(0.65) Down From $(0.38) YoY

Athira Pharma (NASDAQ:ATHA) reported quarterly losses of $(0.65) per share. This is a 71.05 percent decrease over losses of $(0.38) per share from the same period last year.

byBenzinga Newsdesk

August 15, 2022

1 minute read

Athira Pharma (NASDAQ:ATHA) reported quarterly losses of $(0.65) per share. This is a 71.05 percent decrease over losses of $(0.38) per share from the same period last year.

UPDATE: Granite Point Mortgage Q3 Adj. EPS $0.17 Misses $0.21 Estimate

By Benzinga Newsdesk

November 9, 1:41 AM

Granite Point Mortgage (NYSE:GPMT) reported quarterly earnings of $0.17 per share which missed the analyst consensus estimate of $0.21 by 19.05 percent. This is a 88.89 percent increase over earnings of $0.09 per share

GPMT